CVS Health

CVS Health's profit nearly tripled in the second quarter, beating Wall Street expectations. The company raised its full-year profit forecast to as much as $8.10 per share due to a weight loss drug deal with Eli Lilly.

CVS Health reported second-quarter profit of $2.98 billion with adjusted earnings of $2.58 per share, exceeding Wall Street expectations of $1.87 per share. The company also reported revenue of $106.1 billion, surpassing forecasts of $100.18 billion, and provided a full-year earnings guidance of $7.90 to $8.10 per share.

CVS exceeded estimates and raised guidance due to improvements in its insurance unit. The company announced a collaboration with Eli Lilly to make Zepbound and Foundayo accessible to eligible patients via the CVS Health app.

Sens. Richard Blumenthal (D-Conn.) and Josh Hawley (R-Mo.) are demanding Medicare Advantage insurers provide records and details about their use of AI to deny care. The bipartisan effort follows a government investigation revealing ongoing denials in the program, with lawmakers challenging insurers' claims of reducing barriers to medical services.

The FTC settled a lawsuit with CVS Caremark, alleging it manipulated insulin prices and restricted access, resulting in up to $8.5 billion in patient savings over 10 years. The settlement requires CVS Caremark to change rebate practices and unlock $4.5 billion in pharmacy counter rebates.

Nike is hiring David M. Denton as its new CFO, offering a $7.25 million cash award and other incentives. Denton has prior CFO experience at Pfizer, Lowe’s, and CVS Health. Nike’s recent quarterly results show flat revenue and declining gross margins amid strategic challenges.

Minnesota will receive over $850,000 from a $36.5 million national settlement with CVS Health Corporation over insulin billing fraud. The settlement addresses CVS's over-billing of government-funded healthcare programs like Medicare and Medicaid.

Trump administration officials and Ohio Republicans highlighted investigations into individual Medicaid fraud cases involving $100 million in alleged scams but did not address corporations with large Medicaid contracts, including UnitedHealthcare and CVS Health, which have faced lawsuits and accusations of up-charging by $250 million annually. Acting U.S. Attorney General Todd Blanche emphasized targeting individuals like two Ohio state employees accused of billing $30 million for undelivered services, while corporations with vertically integrated operations remained unmentioned.

CVS Health has recalled tens of thousands of medicated wipes sold in its stores due to concerns that children could access them and potentially be poisoned.

Medicare has started covering obesity drugs for the first time, and companies like Walmart and CVS Health are assisting seniors in navigating this coverage.

States are enacting laws to regulate pharmacy benefit managers (PBMs) like CVS to lower drug prices, requiring transparency and limiting their compensation. CVS and other PBMs are contesting these regulations through lawsuits and lobbying, arguing they help reduce costs by promoting generic drugs.

States are enacting laws to regulate pharmacy benefit managers (PBMs) like CVS to lower drug prices, with Tennessee banning PBMs from operating retail pharmacies by 2028. CVS and other PBMs are contesting these regulations through legal action and advertising campaigns, arguing they help reduce drug costs by promoting generic medications.

States are implementing laws to reduce drug prices by regulating pharmacy benefit managers (PBMs) like CVS, which oversee prescription coverage for insurers. Tennessee's law, set to take effect in 2028, prohibits PBMs from operating retail pharmacies, prompting a lawsuit from CVS. Over 60% of U.S. adults express concern about affording prescriptions, with states passing measures to limit PBM compensation and increase transparency.

States are enacting laws to regulate pharmacy benefit managers (PBMs) like CVS to lower drug prices, with Tennessee banning PBMs from operating retail pharmacies by 2028. CVS has sued to avoid closing its pharmacies and spent millions opposing regulations, while a KFF poll highlights widespread public concern over medication affordability.

States are enacting laws to regulate pharmacy benefit managers (PBMs) like CVS to lower drug prices, with Tennessee banning PBMs from operating retail pharmacies by 2028. CVS and other PBMs are contesting these regulations through lawsuits and advertising campaigns, arguing they help reduce drug costs by promoting generic medications.

CVS Health executives discuss using AI and other technologies to reduce administrative burdens in healthcare and deliver more proactive care experiences.

Massachusetts will review a proposal to affiliate 37 CVS MinuteClinic locations with Mass General Brigham to address primary care shortages, with projected annual cost increases ranging from $13 million to $40 million. The plan aims to expand services at MinuteClinics to include preventive care and chronic disease management, potentially serving up to 120,000 adults.

The article discusses upcoming public visibility of drug prices under Trump's most-favored-nation deals, highlighting three new drugs (Baxfendy, Awiqli, and Veppanu). CVS Health is reintroducing Eli Lilly's obesity drug Zepbound to formularies and removing coverage restrictions on Lilly's new weight loss pill Foundayo.

CVS Health will add Zepbound coverage starting October 1 and begin covering Eli Lilly's newly approved obesity treatment, Foundayo, on June 1. The moves expand drug plan accessibility for weight management medications.

A study by CVS Health reveals that many older adults face challenges with digital health tools due to low digital health literacy, including confusing portals, privacy concerns, outdated devices, and spotty internet. Despite these barriers, 86% of Medicare-age adults remain open to using digital health tools if they are designed to match their comfort levels.

CVS Health sued Tennessee after the state passed a law banning pharmacy benefit managers (PBMs) from owning pharmacies, targeting CVS as the only company in Tennessee with both a PBM and physical pharmacies. The law aims to address disparities in drug reimbursement rates between affiliated and non-affiliated pharmacies, with state lawmakers calling it PBM reform. CVS claims the law is unconstitutional and will restrict patient access to medications.

Lena Weissbrot, 32, a Luigi Mangione fangirl, claimed she would kill her mother, a senior CVS Health manager, if her mother became a healthcare executive. The statement was made on Weissbrot's Instagram story following a report revealing her mother's role at the pharmacy chain.

A superfan of Luigi Mangione taunted the victim's family outside court, later revealed to be the daughter of a senior executive at CVS Health. The incident highlights tensions surrounding the case and corporate affiliations.

Corporate America is delivering strong earnings despite economic uncertainty, with 84% of S&P 500 companies topping estimates. Companies like Uber, Disney, and CVS Health are reporting positive results, while some others struggle. The earnings season is one of the best in 20 years.